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ABSTRACT. The testes of five phenotypic women (from four
families) with 5<*-reductase deficiency were studied. In one of
the patients, the enzyme deficiency was similar in the testis and
epididymis and in fibroblasts cultured from the labia majora. In
testes from four of the patients, the concentrations of the 5a-
reduced steroids dihydrotestosterone and 3a-androstanediol
were less than 10% of those in normal subjects. We conclude
that the testis is involved in 5a-reductase deficiency. Impaired
spermatogenesis was evident in testicular biopsies from all five
subjects, and in two, sperm production, as estimated in testicular
homogenates, was less than 10% of normal. The extent to which
spermatogenic arrest is due to 5a-reductase deficiency or testic-
ular maldescent is not clear. {J Clin Endocrinol Metab 63: 1091,
1986)
THE 5a-reductase deficiency is a rare autosomalrecessive mutation that impairs the 5a-oxidore-
duction of steroid hormones, including the conversion of
testosterone to dihydrotestosterone (1). In affected fe-
males, the mutation is phenotypically silent, implying
that 5a-reduced steroid hormones play no obligatory role
in the endocrinology and/or reproduction of women (2,
3). In males, however, dihydrotestosterone mediates vir-
ilization during embryogenesis of the external genitalia
and urethra and a major portion of virilization in post-
natal life (4). As a consequence, males with 5a-reductase
deficiency have a characteristic form of male pseudoher-
maphroditism that was originally termed pseudovaginal
perineoscrotal hypospadias (1, 5). Despite a 46,XY kar-
yotype, testes that secrete normal male levels of testos-
terone, and a normal male excretory duct system (epidid-
ymides, vasa deferentia, seminal vesicles, and ejaculatory
ducts), their ejaculatory ducts terminate in a vagina, and
the external genitalia are either ambiguous or female in
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character. Approximately 60 patients with this disorder
have been characterized, including 22 patients from 18
families studied in Dallas (1, 2, 6-14). Two enzymatic
variants of the disorder are recognized. In the usual form,
5a-reductase activity is so low that the residual protein
cannot be easily characterized; in the other, binding of
steroid and/or NADPH to the mutant enzyme is im-
paired (15). The phenotypic manifestations of these 2
types of defect appear to be identical. In all patients
studied to date, however, 5a-reductase activity, although
low, was not absent, and some dihydrotestosterone for-
mation could be demonstrated.
Several aspects of 5a-reductase deficiency are unre-
solved. One has to do with the role of dihydrotestosterone
in spermatogenesis. Androgen action is essential for the
formation of sperm, and since 5a-reductase activity in
normal testis is low (16), it has been generally assumed
that testosterone is the active androgen that performs
this function. The availability of 46,XY individuals with
5a-reductase deficiency should make it possible to ex-
amine the relation between dihydrotestosterone forma-
tion and spermatogenesis, but study of sperm production
is hampered by three features of the disorder. First, the
common anatomical abnormalities of the ejaculatory
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duct system preclude quantitative collection of the ejac-
ulate, making it difficult to quantify sperm production
directly. Second, histological techniques for quantifying
spermatogenesis can rarely be applied. The testes are
frequently left intact, since at the time of expected pu-
berty, some affected individuals change gender behavior
pattern from female to male (17); when this occurs, the
partial virilization that eventuates is allowed to proceed
unimpaired. Third, the degree of testicular descent var-
ies. In some patients, the testes descend into the labia
majora, whereas in others, there is a variable failure of
the terminal phase of descent. When testicular descent
is incomplete, secondary effects of maldescent on sper-
matogenesis must be separated from any direct effects of
5a-reductase deficiency itself.
As a result of these problems, quantitative studies of
sperm production in mature patients with 5a-reductase
deficiency and descended testes are limited to histological
studies of spermatogenesis in four subjects (2,10,12,18),
an assessment of sperm numbers in a partial ejaculate
from another patient (11), and measurements of sperm
production in two brothers in whom it was possible to
collect ejaculates after surgical repair of the urethra (14).
In five of these patients, spermatogenesis was profoundly
impaired.
We report here studies of the testes of five 46,XY
phenotypic women with 5a-reductase deficiency who
elected to lead lives as women and undergo castration.
In two patients, one or both testes were in the labia
majora, and in three, they were in the inguinal canal. We
quantified sperm production in two patients using tech-
niques of tissue analysis. In addition, we analyzed 5a-
reductase activity in the testis from one patient and the
content of the 5a-reduced androgens dihydrotestosterone
and 3a-androstanediol in the testes of four patients. The
findings document that 5«-reductase deficiency affects
the testes as well as extragonadal tissues, confirm pre-
vious reports that impaired spermatogenesis is common,
and suggest a role for dihydrotestosterone formation in
normal spermatogenesis.
Case Reports
Patient 1, a 16-yr-old girl, was referred to the University of
Illinois Hospital because of primary amenorrhea, virilization,
and failure of breast development. She was born in Mexico.
The external genitalia at birth had been thought to be those of
a normal female. During the preceding 3 yr, a masculine pattern
of muscular development had been noted, and she became
aware of clitoral enlargement. She has two younger normal
sisters and two normal brothers. The family history was unin-
formative.
On physical examination she was 160 cm in height and
weighed 58 kg. A moderate degree of facial acne was present,
but there was no beard. Muscular development of the arms and
chest resembled that of an adolescent male. There was no
female breast development. Pubic hair was Tanner stage IV,
with male type distribution, and some axillary hair was present.
The clitoris measured 4 cm in length. There were separate
urethral and vaginal orifices. Gonads were palpable in the
inguinal canals. The vagina was short and had a narrow orifice.
No cervix was present.
Karyotype was 46,XY. Serum testosterone was 5.8 ng/ml,
and dihydrotestosterone was 0.2 ng/ml. FSH was 11 mlU/ml
(normal, 5-20 mlU/ml), and LH was 7.8 mlU/ml (normal, 5-
20 mlU/ml). Serum 17-hydroxyprogesterone, PRL, GH, corti-
sol, T4, electrolytes, and glucose were normal. Ultrasound of
the pelvis showed a vagina. No uterus or Fallopian tubes were
identified by ultrasonography or computerized tomography of
the pelvis. On the basis of the clinical and laboratory findings,
a tentative diagnosis of 5a-reductase deficiency was made.
Psychological evaluation indicated normal female gender
identity and gender role. A psychiatric consultant concurred in
these findings and found no evidence of depression. There were
no contraindications to corrective surgery of the genitalia and
hormone therapy for female maturation, as requested by the
patient and her parents.
Cystourethroscopy revealed a 3-cm female urethra with poor
trigonal formation and absence of an interureteric ridge. The
bladder wall mucosa and bladder neck were normal. The ure-
thral orifice was located on the anterior wall of the vagina. At
surgery a gubernaculum-like structure was found to connect
each testis to the ipsilateral labial structure. The epididymis,
vas deferens, and spermatic vessels appeared normal. The
anatomy of the Wolffian duct-derived structures was examined
in detail. After injection of indigo carmine dye into each vas,
dye entered the vagina through small orifices in its lateral walls.
Contrast material was then injected into the vasa, and a radio-
graph was taken. Each vas deferens and seminal vesicle was
opacified, and the seminal vesicles were found to terminate in
the region of the vagina. Bilateral orchiectomy and clitoroplasty
were performed. Each testis measured 1.8 x 1.5 x 1.0 cm. On
histological examination, the basement membrane of the sper-
matogenic tubules was normal, and the tubules were lined by
Sertoli cells. No spermatogenesis was seen in one testis, and
only spermatogonia and primary spermatocytes were seen in
the other testis. Both testes contained foci of Leydig cell
hyperplasia. The resected shaft of the phallus measured 3 x 2
X 1 cm; histological sections showed a segment of erectile tissue
surrounded by fibrous tissue. At surgery, biopsy of the foreskin
was obtained for propagation of fibroblasts. Portions of the
testes and epididymides were used for measurement of 5a-
reductase and androgen content and for electron microscopy.
After surgery, the patient was given conjugated estrogens,
first 0.625 mg daily and later 1.25 mg daily. The patient
returned to school with full activity, including participation in
sports. Examination 4 months later revealed marked improve-
ment in facial acne. Breast development had reached Tanner
stage II.
Patient 2, an American Indian, was referred at age 16 yr to
the St. Joseph's Medical Center (Phoenix, AZ) because of
clitoromegaly. She had been raised as a female, with no recog-
nized ambiguity of the genitalia. At the age of 13 yr, her voice
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began to deepen, and clitoromegaly was noted. At age 14 yr,
the clitoris measured 1 x 3 cm. She had no breast enlargement,
pubic hair and urethral orifice were female in character, and a
blind-ending vaginal pouch was present. Testes were palpable
in the right labioscrotal fold ( 3 x 5 cm) and the left inguinal
canal ( 2 x 3 cm). The karyotype was 46,XY, and the plasma
testosterone level was 10 ng/ml. Eight siblings have normal
genitalia, and one sibling with ambiguous genitalia died in
infancy. Because of apparent apprehension on her part, further
workup was delayed. At age 16 yr, she was 178 cm in height,
thin and well muscled, and had fine hairs on the upper lip and
sideburn areas but none on the chin or cheeks. No breast tissue
was palpable. The pubic hair was Tanner stage I, and the
clitoris measured 2 x 6 cm. One testis was present in the right
labial fold, and the other was in the left inguinal canal. There
was a single perineal opening, which was 3 cm deep. No uterus
could be felt on bimanual examination. Repeat karyotype was
46,XY. Her serum hormone levels were as follows: LH, 7 inlU/
ml; FSH, 4.5 mlU/ml; testosterone, 11.4 ng/ml; and dihydro-
testosterone, 0.33 ng/ml. A diagnosis of 5a-reductase deficiency
was made. Because of the desire of the patient and her parents
that she continue life as a woman, the decision was made to
remove the testes and perform a clitoral resection. At the time
of surgery, contrast medium was injected into the vasa defer-
entia, and the presence of seminal vesicles and ejaculatory
ducts that terminated in the vagina was documented by x-ray.
Spermatogenesis was ongoing in both testes, as evidenced by
the presence of spermatogonia, spermatocytes, and spermatids.
Samples of testes were processed for electron microscopy, and
a biopsy of labia majora was obtained for propagation of skin
fibroblasts. After surgery, the patient was treated with ethinyl
estradiol.
Patient 3 was thought to be a normal female until the age of
16 yr, when she sought medical advice because of failure of
breast development and primary amenorrhea. The parents are
unrelated. She has two siblings, a sister who has regular menses
and an affected sister who is described below. Physical exami-
nation revealed no signs of feminization; no breast tissue was
palpable. Her voice was deep, but no acne or temporal recession
of the hairline was present. Testes were palpable in the inguinal
canals. Clitoromegaly and a blind-ending vagina were present.
Laboratory analyses performed at the Universities of Bonn and
Innsbruck revealed the following: serum testosterone, 9 ng/ml
(normal, 3.5-7); dihydrotestosterone, 0.04 ng/mg (normal,
0.35-0.9); LH, 11.6 mlU/ml (normal, 3-10); and FSH, 8.7 mlU/
ml (normal, 2-10). Cystourethrography showed a female ure-
thra. The karyotype was 46,XY. Exploratory laparoscopy of
the pelvis revealed bilateral testes and epididymides and the
absence of a uterus and Fallopian tubes. Injection of contrast
medium into the vasa deferentia showed seminal vesicles and
ejaculatory ducts that terminated in the vagina. Since the
psychosexual orientation of the patient was female, orchiec-
tomy and clitoral resection were performed, at which time a
biopsy of labia majora was obtained for the propagation of skin
fibroblasts. On histological examination of the testes, sperma-
togonia were identified, but no spermatocytes or spermatids
were present. One testis was frozen and shipped to Dallas for
analysis. This histology of the epididymis was normal. Since
surgery, the patient has been treated with estrogens and pro-
gestogens and has made a successful adjustment as a woman.
Patient 4, the youngest sibling of patient 3, was thought to
be a normal girl. She was first evaluated at the age of 14 yr
because of failure of breast development and amenorrhea. Phys-
ical examination revealed a boyish habitus, low voice, no breast
tissue, bilateral inguinal testes, a large phallus, a normal female
urethral orifice, and a blind-ending vagina. Laboratory analyses
at the Universities of Bonn and Innsbruck revealed a serum
testosterone level of 3.6 ng/ml (normal, 3.5-7), dihydrotestos-
terone level of 0.1 ng/ml (normal, 0.35-0.9), LH level of 9.1
mlU/ml (normal, 3-10), and FSH level of 20 mlU/ml (normal,
2-10). A cystourethrogram showed a female urethra. Since the
psychosexual orientation was female, an orchiectomy was per-
formed. On this occasion, an x-ray contrast study revealed
bilateral seminal vesicles and ejaculatory ducts that emptied
into the vagina. Histological examination Of the testes revealed
spermatogonia but no spermatocytes or spermatids; the struc-
ture of the epididymis appeared normal. One testis was frozen
and shipped to Dallas for analysis. Since the time of surgery,
the patient has been treated with estradiol. A clitoroplasty is
planned.
Patient 5 was a 35-yf-old Vietnamese woman seen at the
Harbor/UCLA Medical Center because of primary amenorrhea.
A younger sibling was known to have male pseudohermaphro-
ditism. This patient was noted to have no palpable breast tissue,
normal axillary and pubic hair, no facial hair, a 4-cm clitoris, a
deepened posterior fourchette and small vaginal orifice, a blind-
ending vagina that measured 1 X 3.5 cm, and testes in both
labia majora. The karyotype was 46,XY. Serum testosterone
was 6.7 ng/ml, dihydrotestosterone was 0.2 ng/ml, LH was 30
mlU/ml, and FSH was 32 mlU/ml. A biopsy of the labia majora
was obtained for propagation of skin fibroblasts. Because of
female gender identity, the decision was made to remove the
testes and perform a clitoral resection. Histological examina-
tion of the testes (each of which measured 4 X 2 x 2 cm)
revealed that spermatogenesis was defective, in that some tu-
bules contained Sertoli cells only, some tubules were hyalinized,
and only occasional tubules contained all types of germ cells
from spermatogbnia to mature spermatids. The histology of the
epididymis was that of a normal male. The lower Wolffian duct
system was not characterized. At the time of surgery, one testis
was frozen and shipped to Dallas for analysis.
Materials and Methods
Assay of 5a-reductase and androgen receptor in cultured skin
fibroblasts
The techniques for the propagation of fibroblasts and assay
of 5a-reductase and androgen receptor were described previ-
ously (15, 19).
Assay of 5a-reductase in testis and epididyrriis
Testes from patient 1 obtained at surgery and a normal testis
obtained at postmortem examination were dissected free of
epididymis, immediately frozen in dry ice, and stored in liquid
nitrogen. To prepare microsomes, aliquots of testis and epidid-
ymis were minced and homogenized in 3 vol 10 mM Tris-Cl
1094 JOHNSON ET AL. JCE & M • 1986
Vol63«No5
buffer, pH 7.4, containing 0.25 M sucrose and 1 mM EDTA,
first in a Polytron (Brinkmann Instruments, Westbury NY)
and then in a Dounce homogenizer (Kontes Co., Vineland, NJ).
The homogenates then were centrifuged at 200,000 X g for 30
min, and the pellets (termed microsomes) were washed three
times in 10 rilM Tris buffer, pH 7.4, resuspended in the same
buffer containing 20% glycerol, and either assayed immediately
or frozen at -70 C for subsequent assay.
Assays for 5<*-reductase activity contained 0.25 nM testoster-
one, 0.4 nM (10,000 dpm) [4-14C]dihydrotestosterone, 1 mM
NADPH, 100 ng BSA, microsomes from testis (0.7-1.2 mg
protein) or epididymis (0.01-0.02 mg protein), and 0.1 M Tris-
citrate buffer, pH 5.5, in a total volume of 0.1 ml. Initial
incubation, extraction, and analysis of dihydrotestosterone for-
mation were as described previously (15). In incubations con-
taining testicular microsomes, more than 90% of the [14C]
dihydrotestosterone was metabolized to 5a-androstane-3a,17j8-
diol (3a-androstanediol), and a different method was used for
assessing 5a-reductase activity. The area containing [14C]3a-
androstanediol was scraped, and the steroid(s) was eluted into
ethyl acetate. After evaporation, 3a-androstanediol was acety-
lated by incubation with acetic anhydride and pyridine, and
the diacetate was purified by sequential thin layer chromatog-
raphy in dichloromethane-ethyl ether (98:2, vol/vol) and di-
chloromethane-ethyl acetate (99:1, vol/vol). No change in the
ratios of 3H to 14C 3a-androstanediol diacetate occurred be-
tween the first and second thin layer chromatographic proce-
dures or in a subsequent recrystallization step (data not shown).
5a-Reductase activity was calculated using the 3H to 14C ratio
of the 3a-androstanediol diacetate after the second chromato-
graphic procedure.
RIA of testicular androgens
Testes obtained at autopsy within 12 h of death or within 20
min of removal at surgery were stored frozen. To assay andro-
gen content, 0.25- to 1-g portions were minced and transferred
to extraction tubes; after the addition of recovery tracers
(~5000 dpm each of [l,2,4,5,6,7-3H]dihydrotestosterone and
[l,2,4,5,6,7-3H]3a-androstanediol and 2500 dpm [1,2,6,7-3H]-
testosterone), the samples were digested and extracted, as
described previously (20). Separation of testosterone, dihydro-
testosterone, and 3a-androstanediol was achieved by chroma-
tography columns containing 1 g of a Celite-ethylene glycol
mixture (1 g-0.75 ml) in 5-ml pipets. After washing the columns
with 5 ml isooctane, the samples were loaded on the columns
in 1 ml 2% ethyl acetate in isooctane and sequentially eluted
with 5 ml isooctane (discarded), 5 ml 5% benzene in isooctane
(collected for dihydrotestosterone), 10 ml 20% benzene in iso-
octane (discard 3 ml, collect 4 ml for testosterone, discard 3
ml), and 5 ml 7.5% ethyl acetate in isooctane (collected for 3a-
androstanediol). To minimize cross-contamination of the sam-
ples, the dihydrotestosterone and 3a-androstanediol fractions
were pooled separately after the first chromatography, and each
was rechromatographed on Celite columns. In this system, the
potential contamination of dihydrotestosterone by testosterone
was approximately 0.2%, and the contamination of 3a-andro-
stanediol by testosterone was about 0.9% (results not shown).
After chromatography, the various androgeh-containing
fractions were dried and reconstituted in 1.0 ml phosphate-
buffered saline containing 0.1% gelatin. Aliquots were assayed
for radioactivity to estimate recoveries (which ranged from 50-
80% for testosterone and from 10-50% for dihydrotestosterone
and 3a-androstanediol). Testosterone and 3a-androstanediol
were measured by RIA using a commercial antiserum (Radioas-
say Systems Laboratories, Inc., Carson, CA), which cross-reacts
with dihydrotestosterone (19%), 3a-androstanediol (3%), and
1% or less with other steroids. Dihydrotestosterone was meas-
ured with antiserum from radioassay Systems Laboratories that
cross-reacts with testosterone (23%), 5a-androstane-3,17-dione
(17%), androstenedione (2%), and 1% or less with other ste-
roids.
Histometric analysis of Leydig cells and seminiferous tubules
The techniques used in the histometric analysis of Leydig
cells (21) and seminiferous tubules (22) have been described.
In brief, 5-10 pieces (~3 mm3) of testicular tissue were fixed in
glutaraldehyde and then in osmium, dehydrated in alcohol,
embedded in Epon 812, sectioned at 0.5 nm, stained with
toluidine blue, and observed under bright field microscopy. The
percentage (volume density) of testicular tissue occupied by
various components of Leydig cells and seminiferous tubules,
the number of Leydig cells per testis (22), the volume of an
individual Leydig cell nucleus and the volume of a single Leydig
cell were estimated. For comparison with normal testes, 95%
confidence limits were calculated for a group of 15 previously
studied men (33 ± 9 yr of age) (21, 22).
Estimation of daily sperm production
Daily sperm production, an estimate of the total number of
sperm produced per testis/day, was determined from testicular
homogenates prepared as described previously (23). To express
spermatogenesis on a daily production basis, the number of
spermatids was divided by the lifespan (duration of stages of
the cycle of seminiferous epithelium in which the spermatids
occur) of the spermatids.
Electron microscopy
Ultrathin Epon sections were stained with uranyl acetate
and lead citrate before being examined by electron microscopy,
as described previously (24).
Results
The patients reported here have typical phenotypic
and endocrine features of 5«-reductase deficiency, and
the studies of 5a-reductase activity and androgen binding
in fibroblasts cultured from the labia majora of four of
the patients are in keeping with this diagnosis (Table 1).
Androgen receptor levels were normal in the fibroblasts.
In three of the women (patients 1,2, and 5), 5a-reductase
activity was low and was not studied further; these
findings are characteristic of the most common form of
5a-reductase deficiency (1). In patient 3, the activity of
the enzyme at pH 5.5 was normal, but the enzyme had
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Methods for the propagation of fibroblasts and for the assay of 5a-reductase and androgen receptor were described previously (15, 19). —, Not
done. Bmox, Maximum binding.
abnormal properties, as evidenced by enhanced thermo-
lability at 45 C, a high apparent Km for testosterone, and
an abnormal pH optimum; the defect in this patient falls
into the category of qualitatively abnormal 5a-reductase
(1, 10, 15). A skin biopsy was not obtained from patient
4.
In one experiment, aliquots of testis and epididymis
from patient 1 and from a normal testis and epididymis
obtained at autopsy were stored in liquid nitrogen and
subsequently assayed for 5a-reductase (Table 2). As re-
ported for another patient (9), enzyme activity was sim-
ilarly low in the epididymis and cultured fibroblasts from
the same patient. In addition, the enzyme was undetect-
able in the testis from patient 1. We conclude that the
enzyme deficiency previously characterized in biopsies of
genital skin and epididymis (7, 9) and in fibroblasts
cultured from genital skin (25) is also expressed in the
testis in this patient.
This conclusion is strengthened by studies of the an-
drogen content of testis from six normal men, one woman
with testicular feminization, and four of the patients
with 5a-reductase deficiency (Fig. 1). In these studies,
the average hormone levels in normal testes were: tes-
tosterone, 70 ng/mg protein; dihydrotestosterone, 0.5 ng/
mg protein; and 3a-androstanediol, 2.5 ng/mg protein.
The total concentration of 5a-reduced metabolites in the
testis (dihydrotestosterone plus 3a-androstanediol) was
about 4% that of testosterone itself, a percentage of 5a-
reduced metabolites similar to that in the testis of the
patient with testicular feminization. In the patients with













The preparation of microsomes and the assay of 5a-reductase are











FIG. 1. Mean (±SEM) testosterone, dihydrotestosterone, and 3a-an-
drostanediol levels in the testes of six normal men, one patient with
testicular feminization, and four patients with 5a-reductase deficiency.
The six normal testes included three samples removed at autopsy from
men who died accidental deaths and three testes removed at surgery
from men with prostatic carcinoma. The patient with testicular fem-
inization was a patient of Dr. LaDonna Immken, University of Texas
Health Science Center (Houston, TX), and the sample was frozen and
shipped to us in dry ice. The patients with 5a-reductase deficiency
were patients 1, 3, 4, and 5. The procedures for the collection and
storage of samples and extraction and analysis of steroids are described
in the text. ND, Not detectable.
5a-reductase deficiency, the mean testosterone content
was similar to that of the normal testes, but the levels of
the two 5a-reduced androgens were low. The finding of
low testicular levels of 5a-reduced androgens is in keep-
ing with the low 5a-reductase activity in patient 1.
The histological characteristics of the testes of patients
1 and 2 are shown in Figs. 2 and 3. Spermatogenesis was
quantified in both (Table 3). By light and electron mi-
croscopy, the Leydig cells and interstitial compartment
were unremarkable. The seminiferous epithelium com-
prised Sertoli cells, spermatogonia, and primary sper-
matocytes. In patient 1, no mature spermatids were
visible (Fig. 2), whereas in patient 2, some immature and
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FIG. 2. Photomicrographs (a and b) and
electron micrograph (c) of the intersti-
tium and seminiferous tubules in the
right testis from patient 1 with 5a-re-
ductase deficiency, a) The interstitium
surrounding tubules contains Leydig
cells which appear normal (LC). How-
ever, occasionally, degenerative Leydig
cells with dark to pyknotic nuclei (D)
are present. The boundary tissue (BT)
around the tubules appears of normal
thickness, with two to four layers of
myoid cells. The seminiferous epithe-
lium is composed of Sertoli cells (SC),
spermatogonia (SG), and primary sper-
matocytes (PS), b) A higher magnifica-
tion photomicrograph reveals the pres-
ence of apparently normal, well devel-
oped pachytene primary spermatocytes
(PPS) and Sertoli cells (SC) in the sem-
iniferous epithelium. The lumen is pres-
ent, and the boundary tissue (BT) ap-
pears normal, c) This electron micro-
graph portrays the upper portion of the
boundary tissue and the lower portion of
the seminiferous epithelium. The bound-
ary tissue is characterized by myoid cells
(MC), collagen fibers (C), and a basal
lamina (BL). Within the seminiferous
epithelium is the cytoplasm of a sper-
matogonium (SG) and the basal region
of several Sertoli cells. Junctional com-
plexes (JC) between adjacent Sertoli
cells have the typical apposition of
plasma membranes paralleled by profiles
of endoplasmic reticulum. Typical pro-
files of rough endoplasmic reticulum
(RER), smooth endoplasmic reticulum
(SER), mitochondria (M), and lipid
droplets (LD) are present. The indented
nuclear envelope, euchromatic nucleo-
plasm, and large nucleolus are character-
istic of Sertoli cell nuclei (N). Bar
lengths are 10, 5, and 1 nm for a, b, and
c, respectively.
mature spermatids were present (Fig. 3). Quantitative
rnorphometric studies were performed on these testes
(Table 3). The testis size was normal in patient 2 and
small in patient 1. The Leydig cell histology was normal,
and the number of Leydig cells per g tissue and per testis
was high (possibly due to the young age of the patients
compared to the normal men). The seminiferous epithe-
lium was relatively normal, whereas the lumen and di-
ameter of the seminiferous tubules were small. Daily
sperm production in patient 1 was undetectable and in
patient 2 was about 10% of normal.
Discussion
The testes from five 46,XY individuals with 5a-reduc-
tase deficiency were used for histological, enzymatic, and
androgen assays. In contrast to many untreated patients
with this disorder, who undergo apparent reversal of
gender role behavior from female to male at the time of
expected puberty (13,17), these five women were studied
because of primary amenorrhea. These patients elected
to undergo a treatment regimen designed to reinforce the
female phenotype. Postpubertal function as women has
been described previously in this disorder (1, 7). It is not
known at present why some individuals undergo reversal
of gender role behavior and some do not, although it is
our impression that the group who elect to maintain
female gender behavior have more profound defects in
dihydrotestosterone formation and, hence, virilize to a
lesser degree at the time of expected puberty than do
5a-REDUCTASE DEFICIENCY 1097
FIG. 3. Photomicrographs (a and b) and
electron micrograph (c) of the intersti-
tium and seminiferous tubules in the
testis from patient 2 with 5a-reductase
deficiency, a and b) Leydig cells (LC) in
the interstitium appear normal. The
boundary tissue (BT) constituting the
outer portion of the tubule is of normal
thickness. In addition to Sertoli cells
(SC), the seminiferous epithelium in-
cludes spermatogonia (SG) and primary
spermatocytes (PS), as well as younger
spermatids with round nuclei (RS) and
mature maturation phase spermatids
(MPS). Degeneration of germ cells ap-
pears at the level of primary spermato-
cytes (DPS) and spermatids with round
nuclei (DRS). c) Sertoli cells are char-
acterized by the euchromatic nuclei (N)
with irregular nuclear surfaces. Mito-
chondria (M) are long and thin. Specific
organelles, including several profiles of
smooth endoplasmic reticulum (SER), a
Charcot-Boettcher's crystalloid (CBC),
lipid droplets (LD), and concentrically
arranged cisternae of rough endoplasmic
reticulum (AL) are present. Large vesi-
cles containing fine granular materials
and resembling peroxisomes (P) were
found between cisternae of the rough
endoplasmic reticulum. Part of a junc-
tional complex between adjacent Sertoli
cells (JC) appears normal. The phago-
cytic function of Sertoli cells is indicated
by the presence of the nuclear remains
of a degenerating primary spermatocyte
(DPS). Bar lengths are 10, 5, and 1 nm
for a, b, and c, respectively.
patients who change gender role from female to male
(13). If this is the case, the subset of patients reported
here may not be representative of the syndrome as a
whole. Nevertheless, the present findings document that
the defect in dihydrotestosterone formation in these
patients involves the testis as well as extragonadal tissues
and are in keeping with some previous reports (10, 12,
13) that impairment of spermatogenesis is common in
the disorder.
The measurement of 5a-reductase in testicular tissue
is technically difficult. The large pool of testosterone
within the testis interferes both with indirect assessment
of 5a-reductase, such as measurement of dihydrotestos-
terone content, as well as with direct assays of the
enzyme itself. Indeed, in the initial studies of 5a-reduc-
tase from this laboratory, it was not possible to document
the presence of the enzyme in testes (16). However,
Oshima et al. (26) and Payne et al. (27) subsequently
found the enzyme in the rat testis. Furthermore, Ito and
Horton (28) reported that small amounts of dihydrotes-
tosterone are secreted by the human testis. In the rabbit,
a 5a-reduced androgen, 3a-androstanediol, is secreted by
the testis at a high rate, second only to testosterone (29).
In the present study, we documented 5a-reductase activ-
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TABLE 3. Leydig cells and seminiferous tubule morphometrics and daily sperm production in 2 patients with 5a-reductase deficiency and 15
normal adult men
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" n = 16, based on the data of Neaves et al. (21) and Johnson et al. (22).
ity in washed microsomes from normal human testis.
Two 5a-reduced androgens, dihydrotestosterone and 3a-
androstanediol, were present in the normal testis at
levels about 4% that of testosterone. The measurements
in the present study were in extracts of whole tissue, and
it is possible that 5«-reduced androgens in some com-
partments of the testis, such as the spermatogenic tu-
bules, may constitute an important physiological pool.
Indeed, these findings raise the possibility that 5a-re-
duced steroids play a role in spermatogenesis.
The nature of androgen control of spermatogenesis is
unclear. The developing spermatocytes themselves do
not require the direct action of androgen (30), and it is
assumed that the hormonal effect is exerted at the level
of the Sertoli cell. In the rat, the androgen receptor in
the spermatogenic tubule (31) is similar in its binding
specificity to that in the prostate, in that dihydrotestos-
terone is the preferred binding ligand. If the action of
androgen on spermatogenesis, like that of most other
androgen effects, is mediated by dihydrotestosterone,
then the only known direct physiological actions of tes-
tosterone are to mediate virilization of the Wolffian ducts
during embryogenesis and regulate the production of LH
in males (1).
The histological studies in these patients confirm pre-
vious reports that spermatogenesis is markedly impaired
in some patients with this disorder. The two patients
who had quantitative estimates of sperm production
(patients 1 and 2) and three patients previously reported
(10, 12, 13) all had major defects in spermatogenesis.
Two of the five produced no sperm, and in the other
three sperm production was less than 10% of normal.
Furthermore, by light microscopy the remaining three
patients (patients 3-5) and most, but not all, of those
previously described (2, 9, 18) also had defective sper-
matogenesis. It is possible that profound impairment of
spermatogenesis is a general property only in the subset
of individuals with the most severe impairment of dihy-
drotestosterone formation. Unfortunately, it is not pos-
sible to be certain whether the defect in spermatogenesis
is the consequence of dihydrotestosterone deficiency or
is, instead, a secondary phenomenon. All five of these
patients had partially descended testes, the testis being
located in the inguinal canal or in the labia majora.
Testicular maldescent is known to be associated with
impairment of spermatogenesis, although the degree of
impairment in high scrotal testes is not necessarily com-
plete (32), and it is unclear whether descent into the
labia majora is equivalent to descent into a scrotum.
Thus, we cannot exclude the possibility that thermal
5a-REDUCTASE DEFICIENCY 1099
injury associated with a high scrotal or labial testis,
rather than 5a-reductase deficiency per se, might con-
tribute to or cause the impaired spermatogenesis in pa-
tients with 5a-reductase deficiency. To determine the
precise role of dihydrotestosterone in spermatogenesis it
will be necessary to study the effects of potent 5a-
reductase inhibitors on testicular 5a-reductase and sper-
matogenesis (20). Whatever the mechanism, the possi-
bility of fertility in men with this disorder appears un-
likely.
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